Followers | 33 |
Posts | 2666 |
Boards Moderated | 0 |
Alias Born | 10/28/2013 |
Sunday, December 06, 2015 10:35:34 PM
http://seekingalpha.com/article/3642996-mei-pharma-should-be-bought-ahead-of-ash-conference
That data just points to a buyout possibility, in my opionion. Just stare at that data for a while and I think you might agree.
Nothing I have heard... but since it really looks that way to me, and I bought in because of it, I don't mind putting the idea in other people's minds.
I worry a little too. I do understand that people, including JBEM, felt a little burned by the last data release. I suppose there could be a negative surprise, but not sure how. Median OS has to be pretty good at this point if that SA Article was accurate. My only concern is whether they can update the CR number in a bad way. I wouldn't think they could change it after trial end date... but maybe if they are still having to watch for the median OS... maybe they also update CR? I don't think so, but a small concern. Of course CR could go up.
There can always be tricks with the stock itself... but so far nothing. I don't consider the recent employee benefit / dilution a big deal. I hope it is them patting themselves on the back for a job well done, and possibly, positioning themselves for aquisition... or partnering for phase 3 with associated SP rise and liquidity.
But I have no inside info, nor anything beyond the recent PR's and reports.
Recent MEIP News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 12/20/2024 10:20:05 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/20/2024 10:15:02 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/20/2024 10:10:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/25/2024 09:30:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2024 09:10:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 09:05:23 PM
- MEI Pharma Reports First Quarter Fiscal Year 2025 Cash Position • Business Wire • 11/12/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2024 08:05:08 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/19/2024 09:20:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2024 09:05:07 PM
- MEI Pharma Reports Fiscal Year End 2024 Cash Position • Business Wire • 09/19/2024 08:01:00 PM
- MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives • Business Wire • 08/12/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 08:05:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 08:05:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/22/2024 09:25:09 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/22/2024 08:06:33 PM
- MEI Pharma to Consider Strategic Alternatives • Business Wire • 07/22/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 08:00:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 05:00:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2024 08:00:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:02:15 PM
- MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights • Business Wire • 05/09/2024 08:02:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:00:47 PM
- MEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344 • Business Wire • 04/11/2024 12:02:00 PM
- MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients • Business Wire • 04/11/2024 12:00:00 PM
Basanite, Inc. to Open New Production and Distribution Facility in Northeast Ohio • BASA • Jan 2, 2025 8:28 AM
The Crypto Company Highlights Blockchain Training Alliance's Successes and Momentum for 2025 • CRCW • Dec 26, 2024 8:58 AM
Hertz Energy Provides Antimony and Critical Minerals Projects Update and Announces Financing • HZLIF • Dec 20, 2024 9:00 AM
North Bay Resources Announces Arrival of 42 Tons Gold Ore at Bishop Gold Mill, California • NBRI • Dec 20, 2024 9:00 AM
Consumer Automotive Finance Subsidiary Drago Knives Narrows Down Potential Partner to Manufacture Patented Throwing Knives • CAFI • Dec 20, 2024 9:00 AM
$ASNS - Is this the Next Big Cybersecurity Stock? How Actelis Networks is Revolutionizing Critical Infrastructure Protection • ASNS • Dec 20, 2024 8:50 AM